secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001683168-24-007533
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq panel grants CNS Pharmaceuticals temporary exception until March 11, 2025 to meet bid price rule
--------------------------------------------------------------------------------

- Company received Nasdaq deficiency notice on Sept 12, 2024 for bid price below $1.00 for 30 consecutive days.
- Not eligible for standard 180-day compliance period due to cumulative reverse stock splits of 250:1 or more in prior two years.
- After hearing, Nasdaq panel granted exception until March 11, 2025 to regain compliance.
- Panel reserves right to reconsider; Listing Council may review within 45 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824007533/0001683168-24-007533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824007533/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-007533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer